(Q74012811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

9

G Drobinski

1 reference

8 November 2019

1

G Montalescot

1 reference

8 November 2019

J P Collet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Lison

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R Choussat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Ankri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Vicaut

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

K Perlemuter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

F Philippe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D Thomas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

110-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Enhanced shear-induced platelet aggregation in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Fibrinogen after coronary angioplasty as a risk factor for restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Biochemical and pharmacologic inequivalence of low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Effect of Heparin and Heparin Fractions on Platelet Aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

The Platelet Aggregating Effect of Eight Commercial Heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Increased platelet responsiveness following coronary stenting. Heparin as a possible aetiological factor in stent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

von Willebrand factor binding to platelet GpIb initiates signals for platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

Reactivation of unstable angina after the discontinuation of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900695-1

7 January 2021

10.1016/S0735-1097(00)00695-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10898421%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference